Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Where Retatrutide Stands in Clinical Trials Retatrutide is currently in phase 3 evaluation through Eli Lilly's TRIUMPH trial programme, following phase 2 results showing up to 24.2% body weight loss over 48 weeks
Let's understand this more
Thats why the family is successful
But the story becomes far more complicated when looking beyond the scale
Brand-Name Costs (Without Insurance): Monthly List Prices: Wegovy (semaglutide): $1,349 Ozempic (semaglutide): $969 Zepbound (tirzepatide): $1,069 Mounjaro (tirzepatide): $1,069 Saxenda (liraglutide): $1,400 Annual Costs: Semaglutide: $11,628-$16,188/year Tirzepatide: $12,828/year For 18-month treatment: $17,442-$24,282 These prices are unsustainable for most cash-pay patients
US$ 22.44
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 23.73
US$ 28.46
